Mapping of genes that control the antibody response to human factor IX in mice
Open Access
- 1 February 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 105 (3) , 1029-1035
- https://doi.org/10.1182/blood-2004-03-1126
Abstract
We tested the hypothesis that the antibody response to human factor IX in mice is controlled by genetic factors, especially histocompatibility antigens. Seven inbred mouse strains were immunized against human factor IX by adenoviral gene transfer or serial injections of human factor IX protein. A/J mice had the highest antibody response and 2 C57 mouse strains had the lowest response. We used the adenovirus vector to immunize 26 recombinant inbred mouse strains (AXB and BXA) derived from A/J and C57BL/6J mice and observed highly significant linkage (logarithmic odds [LOD] scores ∼4.8) for the polymorphic D17Mit62 marker that is 1 centimorgan (∼300 000 base pair [bp]) from the mouse major histocompatibility complex (MHC) locus (H-2). Experiments in mice with chimeric MHC genes indicated that class IaK or class II H-2 (or both) genes were critical, but other genes contributed to the antibody response. Polymorphic markers from chromosomes 1 and 10 that are near important immunoregulatory genes such as interleukin 10 and the interferon-γ gene show suggestive linkage (LOD scores of ∼2.3-2.6) to the factor IX antibody response. This study confirms the hypothesis that H-2 (and other) genes control factor IX antibody development in mice and suggests their potential importance for factor IX antibody development in humans with hemophilia B.Keywords
This publication has 20 references indexed in Scilit:
- IL-22, in contrast to IL-10, does not induce Ig production, due to absence of a functional IL-22 receptor on activated human B cells.International Immunology, 2002
- Functional mapping of anti-factor IX inhibitors developed in patients with severe hemophilia BBlood, 2001
- The Malmö International Brother Study (MIBS): further support for genetic predisposition to inhibitor developmentHaemophilia, 2001
- Anaphylaxis in Patients with HemophiliaSeminars in Thrombosis and Hemostasis, 2000
- Use of central venous catheters in children with haemophilia: one haemophilia treatment centre experienceHaemophilia, 1997
- Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expressionGene Therapy, 1997
- Factor VIII Inhibitors in Patients with Hemophilia A: Epidemiology of Inhibitor Development and Induction of Immune Tolerance for Factor VIIISeminars in Thrombosis and Hemostasis, 1995
- Epitope mapping of human factor IX inhibitor antibodiesBritish Journal of Haematology, 1994
- Complications of Hemophilia A Treatment: Factor VIII InhibitorsaAnnals of the New York Academy of Sciences, 1991
- Deduced amino acid sequence of mouse blood-coagulation factor IXGene, 1990